Bixiye
QP13-22 Commercial Pharmacy Benefit Exclusion for Apretude, Tezspire™ and Vyvgart™
Taariikhda uu dhaqangalayo Barnaamijka: 09, Feb 2022
Natiijooyinka Raadinta
Soo bandhiga 2671 - 2680 ee natiijooyinka 4130
Bixiye
P5-22 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P6-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P7-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P8-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Sleep Management Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
P9-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective April 4, 2022
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
2022 February Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2022
Bixiye
Anti-COVID19 - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024